Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$69.42 - $100.2 $2.92 Million - $4.22 Million
42,124 New
42,124 $4.17 Million
Q1 2022

May 16, 2022

SELL
$76.55 - $85.89 $57,029 - $63,988
-745 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$79.74 - $93.39 $59,406 - $69,575
745 New
745 $64,000
Q1 2021

May 17, 2021

SELL
$73.8 - $95.67 $1.76 Million - $2.28 Million
-23,797 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$56.69 - $81.69 $1.35 Million - $1.94 Million
23,797 New
23,797 $1.93 Million
Q1 2020

May 15, 2020

SELL
$47.2 - $98.93 $9.18 Million - $19.2 Million
-194,552 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$71.98 - $81.56 $9.85 Million - $11.2 Million
-136,906 Reduced 41.3%
194,552 $15.6 Million
Q3 2019

Nov 14, 2019

BUY
$71.09 - $88.34 $10.1 Million - $12.5 Million
141,941 Added 74.9%
331,458 $25 Million
Q2 2019

Aug 14, 2019

BUY
$67.72 - $84.94 $632,707 - $793,594
9,343 Added 5.19%
189,517 $15.9 Million
Q1 2019

May 14, 2019

BUY
$73.4 - $92.12 $12.2 Million - $15.4 Million
166,752 Added 1242.38%
180,174 $13.6 Million
Q4 2018

Feb 14, 2019

BUY
$70.09 - $88.71 $940,747 - $1.19 Million
13,422 New
13,422 $1.02 Million

Others Institutions Holding ITGR

About Integer Holdings Corp


  • Ticker ITGR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,131,000
  • Market Cap $4.07B
  • Description
  • Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional o...
More about ITGR
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.